Rchr
J-GLOBAL ID：202201020571629471   Update date: Jan. 30, 2024

KARASAWA SATOSHI

カラサワ サトシ | KARASAWA SATOSHI
Affiliation and department：
Chiba University Graduate School of Medicine, Chiba 260-8677, Japan. Department of Emergency and Critical Care Medicine,

About Chiba University Graduate School of Medicine, Chiba 260-8677, Japan. Department of Emergency and Critical Care Medicine,


Job title： assistant professor
Research theme for competitive and other funds  (2)：
  • 2021 - 2024 Validation of apolipoproteinB-100,serum paraoxonase-1,cell-free DNA as a biomarker for mesenteric ischemia
  • 2018 - 2020 Development of treatment method for intestinal ischemia-reperfusion injury using mesenchymal stem cells.
Papers (3)：
  • Satoshi Karasawa, Taka-Aki Nakada, Mamoru Sato, Taku Miyasho, Tadanaga Shimada, Taku Oshima, Koichi Suda, Koichiro Shinozaki, Shigeto Oda. Early Elevation of Cell-Free DNA After Acute Mesenteric Ischemia in Rats. The Journal of surgical research. 2022. 269. 28-35
  • Takehiko Oami, Satoshi Karasawa, Tadanaga Shimada, Taka-Aki Nakada, Toshikazu Abe, Hiroshi Ogura, Atsushi Shiraishi, Shigeki Kushimoto, Daizoh Saitoh, Seitaro Fujishima, et al. Association between low body mass index and increased 28-day mortality of severe sepsis in Japanese cohorts. Scientific reports. 2021. 11. 1. 1615-1615
  • Toshio Suzuki, Yuji Tada, Santhi Gladson, Rintaro Nishimura, Iwao Shimomura, Satoshi Karasawa, Koichiro Tatsumi, James West. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respiratory research. 2017. 18. 1. 177-177
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM